ESC Professional Premium Access

Activation of mitochondrial telomerase reverses relative lymphopenia post myocardial infarction: results from the randomised, double-blinded TACTIC phase IIa pilot trial

Congress Session

About the speaker

Professor Ioakim Spyridopoulos

Newcastle University, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)
0 follower

4 more presentations in this session

Sodium-glucose co-transporter-2 inhibitors after acute myocardial infarction in type 2 diabetes patients: a population-based investigation from South Korea

Speaker: Doctor O. Kwon (Seoul, KR)

Thumbnail

Blood pressure and clinical outcomes in patients with diabetes and stable coronary artery disease in THEMIS

Speaker: Doctor M. Pareek (Copenhagen, DK)

Thumbnail

Effect of rivaroxaban monotherapy vs. combination with anti-platelet therapy in patients with atrial fibrillation and stable coronary artery disease across different body mass index categories

Speaker: Doctor M. Ishii (Nobeoka, JP)

Thumbnail

Direct cost analysis of genetic testing for CYP2C19*2 and *3 loss of function variants in percutaneous coronary intervention patients

Speaker: Doctor S. Huxley (Rochester, US)

Thumbnail

Access the full session

Coronary artery disease - Pharmacotherapy 1

Speakers: Professor I. Spyridopoulos, Doctor O. Kwon, Doctor M. Pareek, Doctor M. Ishii, Doctor S. Huxley
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk